肌肉特异性微小核糖核酸miR-1-3p、miR-133a-3p和miR-133b反映大鼠慢性肩袖修复模型中单剂量唑来膦酸后的肌肉再生
研究在大鼠慢性肩袖损伤修复模型中,于修复后单次皮下注射唑来膦酸100 µg/kg,纵向检测循环骨与肌肉特异性微小核糖核酸并分析冈上肌组织。结果显示两组循环微小核糖核酸表达显著不同,对照组肌肉特异性miR-1-3p、miR-133a-3p和miR-133b显著下调;组织学显示手术侧再生肌纤维比例显著高于非手术侧。作者认为这些微小核糖核酸或可作为肩袖修复后肌肉再生的生物标志物。
要点
- 对照组肌肉特异性miR-1-3p(P=0.004)、miR-133a-3p(P<0.001)和miR-133b(P<0.001)显著下调。
- 两组手术侧(左侧)再生肌纤维比例均显著高于非手术侧(右侧)(P=0.002)。
- 非手术侧干预组再生肌纤维比例显著高于对照组(P=0.031),但干预组双侧肌纤维横截面积均显著小于对照组双侧(P<0.001)。
核心结论
- 大鼠慢性缺损模型肩袖修复后辅助单剂量唑来膦酸导致骨与肌肉特异性微小核糖核酸水平出现显著差异。
- 作者认为miR-1-3p、miR-133a-3p和miR-133b或可作为肩袖修复后肌肉再生的生物标志物。
- 作者指出辅助唑来膦酸治疗或可改善人类慢性肩袖修复后的肌肉再生,从而对抗脂肪肌肉浸润和萎缩。
研究设计与样本
- 对照实验室研究,共34只雄性Sprague-Dawley大鼠接受单侧(左侧)冈上肌腱切断,3周后行延迟经骨肩袖修复,修复后8周处死。
- 动物随机分为2组:对照组在肩袖修复后1天皮下注射1 mL生理盐水,干预组皮下单次注射100 µg/kg体重的唑来膦酸。
- 全部34只动物在3个时间点均进行微小核糖核酸分析,每组4只动物进行组织学分析和基因表达分析。
主要发现
- 两组循环微小核糖核酸表达存在显著差异;对照组肌肉特异性miR-1-3p(P=0.004)、miR-133a-3p(P<0.001)和miR-133b(P<0.001)显著下调。
- 组织学分析显示两组手术侧(左侧)再生肌纤维比例均显著高于非手术侧(右侧)(P=0.002)。
- 非手术侧干预组再生肌纤维比例显著高于对照组(P=0.031)。
- 干预组双侧肌纤维横截面积均显著小于对照组双侧(P<0.001)。
- 干预组内非手术侧肌肉发育/再生标志基因胚胎型肌球蛋白重链(P=0.017)和新生儿型肌球蛋白重链(P=0.016)表达水平显著高于手术侧。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Zoledronic acid improves bone microarchitecture and biomechanical properties after chronic rotator cuff repair (RCR) in rats. Besides the positive effects of zoledronic acid on bone mineral density and bone microarchitecture, bisphosphonates have positive effects on skeletal muscle function. PURPOSES/HYPOTHESIS: The purposes of this study were to (1) longitudinally evaluate circulating bone- and muscle-specific serum micro-ribonucleic acids (miRNAs) and (2) investigate supraspinatus muscle tissue after tenotomy and delayed RCR in a rat model. It was hypothesized that zoledronic acid would improve muscle regeneration after chronic RCR in rats. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 34 male Sprague-Dawley rats underwent unilateral (left) supraspinatus tenotomy (time point 1) with delayed transosseous RCR after 3 weeks (time point 2). All rats were sacrificed 8 weeks after RCR (time point 3). Animals were randomly assigned to 2 groups. One day after RCR, the control group was given 1 mL of subcutaneous saline solution, and the intervention group was treated with a subcutaneous single-dose of 100 µg/kg body weight of zoledronic acid. All 34 study animals underwent miRNA analysis at all 3 time points. In 4 animals of each group, histological analyses as well as gene expression analyses were conducted. RESULTS: Circulating miRNAs showed significantly different expressions between both study groups. In the control group, a significant downregulation was observed for muscle-specific miR-1-3p (P = .004), miR-133a-3p (P < .001), and miR-133b (P < .001). Histological analyses showed significantly higher rates of regenerating myofibers on the operated side (left) of both study groups compared with the nonoperated side (right; P = .002). On the nonoperated side, significantly higher rates of regenerating myofibers were observed in the intervention group compared with the control group (P = .031). The myofiber cross-sectional area revealed significantly smaller myofibers on both sides within the intervention group compared with both sides of the control group (P < .001). Within the intervention group, significantly higher expression levels of muscle development/regeneration marker genes embryonal Myosin heavy chain (P = .017) and neonatal Myosin heavy chain (P = .016) were observed on the nonoperated side compared with the operated side. CONCLUSION: An adjuvant single-dose of zoledronic acid after RCR in a chronic defect model in rats led to significant differences in bone- and muscle-specific miRNA levels. Therefore, miR-1-3p, miR-133a-3p, and miR-133b might be used as biomarkers for muscle regeneration after RCR. CLINICAL RELEVANCE: Adjuvant treatment with zoledronic acid may improve muscle regeneration after chronic RCR in humans, thus counteracting fatty muscle infiltration and atrophy.
引用
- Schanda JE, Heher P, Weigl M, et al. Muscle-Specific Micro-Ribonucleic Acids miR-1-3p, miR-133a-3p, and miR-133b Reflect Muscle Regeneration After Single-Dose Zoledronic Acid Following Rotator Cuff Repair in a Rodent Chronic Defect Model. Am J Sports Med. 2022. PMID: 36053026. doi:10.1177/03635465221119507
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。